0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Animal-base Gelatin Haemostatic Sponge Market Research Report 2026
Published Date: 2026-02-09
|
Report Code: QYRE-Auto-21D20016
Home | Market Reports | Health| Medical Devices & Equipment
Global Animal base Gelatin Haemostatic Sponge Market Research Report 2026
BUY CHAPTERS

Global Animal-base Gelatin Haemostatic Sponge Market Research Report 2026

Code: QYRE-Auto-21D20016
Report
2026-02-09
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal-base Gelatin Haemostatic Sponge Market Size

The global Animal-base Gelatin Haemostatic Sponge market was valued at US$ 1150 million in 2025 and is anticipated to reach US$ 1501 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Animal-base Gelatin Haemostatic Sponge Market

Animal-base Gelatin Haemostatic Sponge Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Animal-base Gelatin Haemostatic Sponge competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Animal-based gelatin haemostatic sponge is a sterile, absorbable topical haemostat manufactured from purified gelatin derived from animal collagen sources (most commonly porcine or bovine). The material is processed into a porous sponge matrix that can be cut or shaped and applied directly to a bleeding surface during surgery or dental procedures. When placed on a wound, the sponge rapidly absorbs blood and exudate, swells, and provides a mechanical scaffold that supports platelet adhesion and clot formation; it can also be used with topical thrombin to accelerate haemostasis in oozing or diffuse bleeding. Because the sponge is bioresorbable, it is designed to be left in situ when removal is impractical, then gradually degraded and absorbed by the body over time, depending on product design and local conditions. Selection and safe use depend on the surgical site, available space (since swelling can create pressure in confined areas), required size and thickness, and compliance with sterility and biocompatibility requirements. Prices for Animal-base Gelatin Haemostatic Sponges vary widely by brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail). The gross profit margin of major companies in the industry is between 10% – 30%. Small dental cubes typically fall around $0.5–$2.0 per piece. Standard OR sheets/blocks are commonly $20–$40 per piece, while larger formats or premium branded packs can reach $80–$120 per piece. The gross profit margin of major companies in the industry is between 10% – 30%.
The North American market for Animal-base Gelatin Haemostatic Sponge is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Animal-base Gelatin Haemostatic Sponge is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Animal-base Gelatin Haemostatic Sponge include Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Animal-base Gelatin Haemostatic Sponge market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Animal-base Gelatin Haemostatic Sponge. The Animal-base Gelatin Haemostatic Sponge market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Animal-base Gelatin Haemostatic Sponge market comprehensively. Regional market sizes by Type, by Application, by Product Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Animal-base Gelatin Haemostatic Sponge manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Animal-base Gelatin Haemostatic Sponge Market Report

Report Metric Details
Report Name Animal-base Gelatin Haemostatic Sponge Market
Accounted market size in 2025 US$ 1150 million
Forecasted market size in 2032 US$ 1501 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Porcine Gelatin Haemostatic Sponge
  • Cow Gelatin Haemostatic Sponge
  • Others
Segment by Product Form
  • Sponge Sheets
  • Sponge Particles
  • Others
by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, BOENMED, Medelast, JIAXING KENYUE, Medzeel Lifescience, Goodwill Lifesciences, Equimedical, Healthium Medtech, Septodont, Assut Europe, Nanchang Hushida Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Product Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Animal-base Gelatin Haemostatic Sponge manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Animal-base Gelatin Haemostatic Sponge sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Animal-base Gelatin Haemostatic Sponge Market growing?

Ans: The Animal-base Gelatin Haemostatic Sponge Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Animal-base Gelatin Haemostatic Sponge Market size in 2032?

Ans: The Animal-base Gelatin Haemostatic Sponge Market size in 2032 will be US$ 1501 million.

Who are the main players in the Animal-base Gelatin Haemostatic Sponge Market report?

Ans: The main players in the Animal-base Gelatin Haemostatic Sponge Market are Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, BOENMED, Medelast, JIAXING KENYUE, Medzeel Lifescience, Goodwill Lifesciences, Equimedical, Healthium Medtech, Septodont, Assut Europe, Nanchang Hushida Medical Technology

What are the Application segmentation covered in the Animal-base Gelatin Haemostatic Sponge Market report?

Ans: The Applications covered in the Animal-base Gelatin Haemostatic Sponge Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Animal-base Gelatin Haemostatic Sponge Market report?

Ans: The Types covered in the Animal-base Gelatin Haemostatic Sponge Market report are Porcine Gelatin Haemostatic Sponge, Cow Gelatin Haemostatic Sponge, Others

1 Animal-base Gelatin Haemostatic Sponge Market Overview
1.1 Product Definition
1.2 Animal-base Gelatin Haemostatic Sponge by Type
1.2.1 Global Animal-base Gelatin Haemostatic Sponge Market Value by Type: 2025 vs 2032
1.2.2 Porcine Gelatin Haemostatic Sponge
1.2.3 Cow Gelatin Haemostatic Sponge
1.2.4 Others
1.3 Animal-base Gelatin Haemostatic Sponge by Product Form
1.3.1 Global Animal-base Gelatin Haemostatic Sponge Market Value by Product Form: 2025 vs 2032
1.3.2 Sponge Sheets
1.3.3 Sponge Particles
1.3.4 Others
1.4 Animal-base Gelatin Haemostatic Sponge by Application
1.4.1 Global Animal-base Gelatin Haemostatic Sponge Market Value by Application: 2025 vs 2032
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Animal-base Gelatin Haemostatic Sponge Market Size Estimates and Forecasts
1.5.1 Global Animal-base Gelatin Haemostatic Sponge Revenue 2021–2032
1.5.2 Global Animal-base Gelatin Haemostatic Sponge Sales 2021–2032
1.5.3 Global Animal-base Gelatin Haemostatic Sponge Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Animal-base Gelatin Haemostatic Sponge Market Competition by Manufacturers
2.1 Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Manufacturers (2021–2026)
2.2 Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Animal-base Gelatin Haemostatic Sponge Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Animal-base Gelatin Haemostatic Sponge, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Animal-base Gelatin Haemostatic Sponge, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Animal-base Gelatin Haemostatic Sponge, Product Types and Applications
2.7 Global Key Manufacturers of Animal-base Gelatin Haemostatic Sponge, Date of Entry into the Industry
2.8 Global Animal-base Gelatin Haemostatic Sponge Market Competitive Situation and Trends
2.8.1 Global Animal-base Gelatin Haemostatic Sponge Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Animal-base Gelatin Haemostatic Sponge Players Market Share by Revenue
2.8.3 Global Animal-base Gelatin Haemostatic Sponge Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Animal-base Gelatin Haemostatic Sponge Market Scenario by Region
3.1 Global Animal-base Gelatin Haemostatic Sponge Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Animal-base Gelatin Haemostatic Sponge Sales by Region: 2021–2032
3.2.1 Global Animal-base Gelatin Haemostatic Sponge Sales by Region: 2021–2026
3.2.2 Global Animal-base Gelatin Haemostatic Sponge Sales by Region: 2027–2032
3.3 Global Animal-base Gelatin Haemostatic Sponge Revenue by Region: 2021–2032
3.3.1 Global Animal-base Gelatin Haemostatic Sponge Revenue by Region: 2021–2026
3.3.2 Global Animal-base Gelatin Haemostatic Sponge Revenue by Region: 2027–2032
3.4 North America Animal-base Gelatin Haemostatic Sponge Market Facts & Figures by Country
3.4.1 North America Animal-base Gelatin Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Animal-base Gelatin Haemostatic Sponge Sales by Country (2021–2032)
3.4.3 North America Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Animal-base Gelatin Haemostatic Sponge Market Facts & Figures by Country
3.5.1 Europe Animal-base Gelatin Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Animal-base Gelatin Haemostatic Sponge Sales by Country (2021–2032)
3.5.3 Europe Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal-base Gelatin Haemostatic Sponge Market Facts & Figures by Region
3.6.1 Asia Pacific Animal-base Gelatin Haemostatic Sponge Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Animal-base Gelatin Haemostatic Sponge Sales by Region (2021–2032)
3.6.3 Asia Pacific Animal-base Gelatin Haemostatic Sponge Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Animal-base Gelatin Haemostatic Sponge Market Facts & Figures by Country
3.7.1 Latin America Animal-base Gelatin Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Animal-base Gelatin Haemostatic Sponge Sales by Country (2021–2032)
3.7.3 Latin America Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Animal-base Gelatin Haemostatic Sponge Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal-base Gelatin Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Animal-base Gelatin Haemostatic Sponge Sales by Country (2021–2032)
3.8.3 Middle East and Africa Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal-base Gelatin Haemostatic Sponge Sales by Type (2021–2032)
4.1.1 Global Animal-base Gelatin Haemostatic Sponge Sales by Type (2021–2026)
4.1.2 Global Animal-base Gelatin Haemostatic Sponge Sales by Type (2027–2032)
4.1.3 Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Type (2021–2032)
4.2 Global Animal-base Gelatin Haemostatic Sponge Revenue by Type (2021–2032)
4.2.1 Global Animal-base Gelatin Haemostatic Sponge Revenue by Type (2021–2026)
4.2.2 Global Animal-base Gelatin Haemostatic Sponge Revenue by Type (2027–2032)
4.2.3 Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Type (2021–2032)
4.3 Global Animal-base Gelatin Haemostatic Sponge Price by Type (2021–2032)
5 Segment by Application
5.1 Global Animal-base Gelatin Haemostatic Sponge Sales by Application (2021–2032)
5.1.1 Global Animal-base Gelatin Haemostatic Sponge Sales by Application (2021–2026)
5.1.2 Global Animal-base Gelatin Haemostatic Sponge Sales by Application (2027–2032)
5.1.3 Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Application (2021–2032)
5.2 Global Animal-base Gelatin Haemostatic Sponge Revenue by Application (2021–2032)
5.2.1 Global Animal-base Gelatin Haemostatic Sponge Revenue by Application (2021–2026)
5.2.2 Global Animal-base Gelatin Haemostatic Sponge Revenue by Application (2027–2032)
5.2.3 Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Application (2021–2032)
5.3 Global Animal-base Gelatin Haemostatic Sponge Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Johnson & Johnson Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Company Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 B. Braun Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Gelita Medical
6.4.1 Gelita Medical Company Information
6.4.2 Gelita Medical Description and Business Overview
6.4.3 Gelita Medical Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Gelita Medical Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.4.5 Gelita Medical Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Company Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cura Medical Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 Aegis Lifesciences
6.6.1 Aegis Lifesciences Company Information
6.6.2 Aegis Lifesciences Description and Business Overview
6.6.3 Aegis Lifesciences Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aegis Lifesciences Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.6.5 Aegis Lifesciences Recent Developments/Updates
6.7 COLTENE
6.7.1 COLTENE Company Information
6.7.2 COLTENE Description and Business Overview
6.7.3 COLTENE Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 COLTENE Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.7.5 COLTENE Recent Developments/Updates
6.8 Dispotech
6.8.1 Dispotech Company Information
6.8.2 Dispotech Description and Business Overview
6.8.3 Dispotech Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Dispotech Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.8.5 Dispotech Recent Developments/Updates
6.9 Ferrosan Medical Devices
6.9.1 Ferrosan Medical Devices Company Information
6.9.2 Ferrosan Medical Devices Description and Business Overview
6.9.3 Ferrosan Medical Devices Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Ferrosan Medical Devices Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.9.5 Ferrosan Medical Devices Recent Developments/Updates
6.10 EUCARE Pharmaceuticals
6.10.1 EUCARE Pharmaceuticals Company Information
6.10.2 EUCARE Pharmaceuticals Description and Business Overview
6.10.3 EUCARE Pharmaceuticals Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 EUCARE Pharmaceuticals Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.10.5 EUCARE Pharmaceuticals Recent Developments/Updates
6.11 BOENMED
6.11.1 BOENMED Company Information
6.11.2 BOENMED Description and Business Overview
6.11.3 BOENMED Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BOENMED Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.11.5 BOENMED Recent Developments/Updates
6.12 Medelast
6.12.1 Medelast Company Information
6.12.2 Medelast Description and Business Overview
6.12.3 Medelast Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Medelast Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.12.5 Medelast Recent Developments/Updates
6.13 JIAXING KENYUE
6.13.1 JIAXING KENYUE Company Information
6.13.2 JIAXING KENYUE Description and Business Overview
6.13.3 JIAXING KENYUE Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JIAXING KENYUE Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.13.5 JIAXING KENYUE Recent Developments/Updates
6.14 Medzeel Lifescience
6.14.1 Medzeel Lifescience Company Information
6.14.2 Medzeel Lifescience Description and Business Overview
6.14.3 Medzeel Lifescience Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Medzeel Lifescience Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.14.5 Medzeel Lifescience Recent Developments/Updates
6.15 Goodwill Lifesciences
6.15.1 Goodwill Lifesciences Company Information
6.15.2 Goodwill Lifesciences Description and Business Overview
6.15.3 Goodwill Lifesciences Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Goodwill Lifesciences Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.15.5 Goodwill Lifesciences Recent Developments/Updates
6.16 Equimedical
6.16.1 Equimedical Company Information
6.16.2 Equimedical Description and Business Overview
6.16.3 Equimedical Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Equimedical Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.16.5 Equimedical Recent Developments/Updates
6.17 Healthium Medtech
6.17.1 Healthium Medtech Company Information
6.17.2 Healthium Medtech Description and Business Overview
6.17.3 Healthium Medtech Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Healthium Medtech Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.17.5 Healthium Medtech Recent Developments/Updates
6.18 Septodont
6.18.1 Septodont Company Information
6.18.2 Septodont Description and Business Overview
6.18.3 Septodont Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Septodont Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.18.5 Septodont Recent Developments/Updates
6.19 Assut Europe
6.19.1 Assut Europe Company Information
6.19.2 Assut Europe Description and Business Overview
6.19.3 Assut Europe Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Assut Europe Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.19.5 Assut Europe Recent Developments/Updates
6.20 Nanchang Hushida Medical Technology
6.20.1 Nanchang Hushida Medical Technology Company Information
6.20.2 Nanchang Hushida Medical Technology Description and Business Overview
6.20.3 Nanchang Hushida Medical Technology Animal-base Gelatin Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Nanchang Hushida Medical Technology Animal-base Gelatin Haemostatic Sponge Product Portfolio
6.20.5 Nanchang Hushida Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal-base Gelatin Haemostatic Sponge Industry Chain Analysis
7.2 Animal-base Gelatin Haemostatic Sponge Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal-base Gelatin Haemostatic Sponge Production Mode & Process Analysis
7.4 Animal-base Gelatin Haemostatic Sponge Sales and Marketing
7.4.1 Animal-base Gelatin Haemostatic Sponge Sales Channels
7.4.2 Animal-base Gelatin Haemostatic Sponge Distributors
7.5 Animal-base Gelatin Haemostatic Sponge Customer Analysis
8 Animal-base Gelatin Haemostatic Sponge Market Dynamics
8.1 Animal-base Gelatin Haemostatic Sponge Industry Trends
8.2 Animal-base Gelatin Haemostatic Sponge Market Drivers
8.3 Animal-base Gelatin Haemostatic Sponge Market Challenges
8.4 Animal-base Gelatin Haemostatic Sponge Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Animal-base Gelatin Haemostatic Sponge Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Animal-base Gelatin Haemostatic Sponge Market Value by Product Form (US$ Million), 2025 vs 2032
 Table 3. Global Animal-base Gelatin Haemostatic Sponge Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Animal-base Gelatin Haemostatic Sponge Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Animal-base Gelatin Haemostatic Sponge Sales (K Units) of Key Manufacturers (2021–2026)
 Table 6. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Animal-base Gelatin Haemostatic Sponge Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Animal-base Gelatin Haemostatic Sponge Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Animal-base Gelatin Haemostatic Sponge Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Animal-base Gelatin Haemostatic Sponge, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Animal-base Gelatin Haemostatic Sponge, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Animal-base Gelatin Haemostatic Sponge, Product Types and Applications
 Table 13. Global Key Manufacturers of Animal-base Gelatin Haemostatic Sponge, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Animal-base Gelatin Haemostatic Sponge Companies by Tier (Tier 1, Tier 2, Tier 3), based on Animal-base Gelatin Haemostatic Sponge Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Animal-base Gelatin Haemostatic Sponge Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Animal-base Gelatin Haemostatic Sponge Sales by Region (K Units), 2021–2026
 Table 19. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Region (2021–2026)
 Table 20. Global Animal-base Gelatin Haemostatic Sponge Sales by Region (K Units), 2027–2032
 Table 21. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Region (2027–2032)
 Table 22. Global Animal-base Gelatin Haemostatic Sponge Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Region (2021–2026)
 Table 24. Global Animal-base Gelatin Haemostatic Sponge Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Region (2027–2032)
 Table 26. North America Animal-base Gelatin Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 28. North America Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 29. North America Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Animal-base Gelatin Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 33. Europe Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 34. Europe Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Animal-base Gelatin Haemostatic Sponge Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Animal-base Gelatin Haemostatic Sponge Sales by Region (K Units), 2021–2026
 Table 38. Asia Pacific Animal-base Gelatin Haemostatic Sponge Sales by Region (K Units), 2027–2032
 Table 39. Asia Pacific Animal-base Gelatin Haemostatic Sponge Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Animal-base Gelatin Haemostatic Sponge Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Animal-base Gelatin Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 43. Latin America Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 44. Latin America Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 48. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 49. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Animal-base Gelatin Haemostatic Sponge Sales (K Units) by Type (2021–2026)
 Table 52. Global Animal-base Gelatin Haemostatic Sponge Sales (K Units) by Type (2027–2032)
 Table 53. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Type (2021–2026)
 Table 54. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Type (2027–2032)
 Table 55. Global Animal-base Gelatin Haemostatic Sponge Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Animal-base Gelatin Haemostatic Sponge Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Type (2021–2026)
 Table 58. Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Type (2027–2032)
 Table 59. Global Animal-base Gelatin Haemostatic Sponge Price (US$/Unit) by Type (2021–2026)
 Table 60. Global Animal-base Gelatin Haemostatic Sponge Price (US$/Unit) by Type (2027–2032)
 Table 61. Global Animal-base Gelatin Haemostatic Sponge Sales (K Units) by Application (2021–2026)
 Table 62. Global Animal-base Gelatin Haemostatic Sponge Sales (K Units) by Application (2027–2032)
 Table 63. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Application (2021–2026)
 Table 64. Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Application (2027–2032)
 Table 65. Global Animal-base Gelatin Haemostatic Sponge Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Animal-base Gelatin Haemostatic Sponge Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Application (2021–2026)
 Table 68. Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Application (2027–2032)
 Table 69. Global Animal-base Gelatin Haemostatic Sponge Price (US$/Unit) by Application (2021–2026)
 Table 70. Global Animal-base Gelatin Haemostatic Sponge Price (US$/Unit) by Application (2027–2032)
 Table 71. Pfizer Company Information
 Table 72. Pfizer Description and Business Overview
 Table 73. Pfizer Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 74. Pfizer Animal-base Gelatin Haemostatic Sponge Product
 Table 75. Pfizer Recent Developments/Updates
 Table 76. Johnson & Johnson Company Information
 Table 77. Johnson & Johnson Description and Business Overview
 Table 78. Johnson & Johnson Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 79. Johnson & Johnson Animal-base Gelatin Haemostatic Sponge Product
 Table 80. Johnson & Johnson Recent Developments/Updates
 Table 81. B. Braun Company Information
 Table 82. B. Braun Description and Business Overview
 Table 83. B. Braun Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 84. B. Braun Animal-base Gelatin Haemostatic Sponge Product
 Table 85. B. Braun Recent Developments/Updates
 Table 86. Gelita Medical Company Information
 Table 87. Gelita Medical Description and Business Overview
 Table 88. Gelita Medical Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 89. Gelita Medical Animal-base Gelatin Haemostatic Sponge Product
 Table 90. Gelita Medical Recent Developments/Updates
 Table 91. Cura Medical Company Information
 Table 92. Cura Medical Description and Business Overview
 Table 93. Cura Medical Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 94. Cura Medical Animal-base Gelatin Haemostatic Sponge Product
 Table 95. Cura Medical Recent Developments/Updates
 Table 96. Aegis Lifesciences Company Information
 Table 97. Aegis Lifesciences Description and Business Overview
 Table 98. Aegis Lifesciences Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 99. Aegis Lifesciences Animal-base Gelatin Haemostatic Sponge Product
 Table 100. Aegis Lifesciences Recent Developments/Updates
 Table 101. COLTENE Company Information
 Table 102. COLTENE Description and Business Overview
 Table 103. COLTENE Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 104. COLTENE Animal-base Gelatin Haemostatic Sponge Product
 Table 105. COLTENE Recent Developments/Updates
 Table 106. Dispotech Company Information
 Table 107. Dispotech Description and Business Overview
 Table 108. Dispotech Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 109. Dispotech Animal-base Gelatin Haemostatic Sponge Product
 Table 110. Dispotech Recent Developments/Updates
 Table 111. Ferrosan Medical Devices Company Information
 Table 112. Ferrosan Medical Devices Description and Business Overview
 Table 113. Ferrosan Medical Devices Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 114. Ferrosan Medical Devices Animal-base Gelatin Haemostatic Sponge Product
 Table 115. Ferrosan Medical Devices Recent Developments/Updates
 Table 116. EUCARE Pharmaceuticals Company Information
 Table 117. EUCARE Pharmaceuticals Description and Business Overview
 Table 118. EUCARE Pharmaceuticals Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 119. EUCARE Pharmaceuticals Animal-base Gelatin Haemostatic Sponge Product
 Table 120. EUCARE Pharmaceuticals Recent Developments/Updates
 Table 121. BOENMED Company Information
 Table 122. BOENMED Description and Business Overview
 Table 123. BOENMED Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 124. BOENMED Animal-base Gelatin Haemostatic Sponge Product
 Table 125. BOENMED Recent Developments/Updates
 Table 126. Medelast Company Information
 Table 127. Medelast Description and Business Overview
 Table 128. Medelast Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 129. Medelast Animal-base Gelatin Haemostatic Sponge Product
 Table 130. Medelast Recent Developments/Updates
 Table 131. JIAXING KENYUE Company Information
 Table 132. JIAXING KENYUE Description and Business Overview
 Table 133. JIAXING KENYUE Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 134. JIAXING KENYUE Animal-base Gelatin Haemostatic Sponge Product
 Table 135. JIAXING KENYUE Recent Developments/Updates
 Table 136. Medzeel Lifescience Company Information
 Table 137. Medzeel Lifescience Description and Business Overview
 Table 138. Medzeel Lifescience Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 139. Medzeel Lifescience Animal-base Gelatin Haemostatic Sponge Product
 Table 140. Medzeel Lifescience Recent Developments/Updates
 Table 141. Goodwill Lifesciences Company Information
 Table 142. Goodwill Lifesciences Description and Business Overview
 Table 143. Goodwill Lifesciences Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 144. Goodwill Lifesciences Animal-base Gelatin Haemostatic Sponge Product
 Table 145. Goodwill Lifesciences Recent Developments/Updates
 Table 146. Equimedical Company Information
 Table 147. Equimedical Description and Business Overview
 Table 148. Equimedical Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 149. Equimedical Animal-base Gelatin Haemostatic Sponge Product
 Table 150. Equimedical Recent Developments/Updates
 Table 151. Healthium Medtech Company Information
 Table 152. Healthium Medtech Description and Business Overview
 Table 153. Healthium Medtech Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 154. Healthium Medtech Animal-base Gelatin Haemostatic Sponge Product
 Table 155. Healthium Medtech Recent Developments/Updates
 Table 156. Septodont Company Information
 Table 157. Septodont Description and Business Overview
 Table 158. Septodont Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 159. Septodont Animal-base Gelatin Haemostatic Sponge Product
 Table 160. Septodont Recent Developments/Updates
 Table 161. Assut Europe Company Information
 Table 162. Assut Europe Description and Business Overview
 Table 163. Assut Europe Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 164. Assut Europe Animal-base Gelatin Haemostatic Sponge Product
 Table 165. Assut Europe Recent Developments/Updates
 Table 166. Nanchang Hushida Medical Technology Company Information
 Table 167. Nanchang Hushida Medical Technology Description and Business Overview
 Table 168. Nanchang Hushida Medical Technology Animal-base Gelatin Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 169. Nanchang Hushida Medical Technology Animal-base Gelatin Haemostatic Sponge Product
 Table 170. Nanchang Hushida Medical Technology Recent Developments/Updates
 Table 171. Key Raw Materials Lists
 Table 172. Raw Materials Key Suppliers Lists
 Table 173. Animal-base Gelatin Haemostatic Sponge Distributors List
 Table 174. Animal-base Gelatin Haemostatic Sponge Customers List
 Table 175. Animal-base Gelatin Haemostatic Sponge Market Trends
 Table 176. Animal-base Gelatin Haemostatic Sponge Market Drivers
 Table 177. Animal-base Gelatin Haemostatic Sponge Market Challenges
 Table 178. Animal-base Gelatin Haemostatic Sponge Market Restraints
 Table 179. Research Programs/Design for This Report
 Table 180. Key Data Information from Secondary Sources
 Table 181. Key Data Information from Primary Sources
 Table 182. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Animal-base Gelatin Haemostatic Sponge
 Figure 2. Global Animal-base Gelatin Haemostatic Sponge Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Animal-base Gelatin Haemostatic Sponge Market Share by Type: 2025 & 2032
 Figure 4. Porcine Gelatin Haemostatic Sponge Product Picture
 Figure 5. Cow Gelatin Haemostatic Sponge Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Animal-base Gelatin Haemostatic Sponge Market Value by Product Form (US$ Million), 2021–2032
 Figure 8. Global Animal-base Gelatin Haemostatic Sponge Market Share by Product Form: 2025 vs 2032
 Figure 9. Sponge Sheets Product Picture
 Figure 10. Sponge Particles Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Animal-base Gelatin Haemostatic Sponge Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Animal-base Gelatin Haemostatic Sponge Market Share by Application: 2025 & 2032
 Figure 14. Hospitals
 Figure 15. Clinics
 Figure 16. Others
 Figure 17. Global Animal-base Gelatin Haemostatic Sponge Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Animal-base Gelatin Haemostatic Sponge Market Size (US$ Million), 2021–2032
 Figure 19. Global Animal-base Gelatin Haemostatic Sponge Sales (K Units), 2021–2032
 Figure 20. Global Animal-base Gelatin Haemostatic Sponge Average Price (US$/Unit), 2021–2032
 Figure 21. Animal-base Gelatin Haemostatic Sponge Report Years Considered
 Figure 22. Animal-base Gelatin Haemostatic Sponge Sales Share by Manufacturers in 2025
 Figure 23. Global Animal-base Gelatin Haemostatic Sponge Revenue Share by Manufacturers in 2025
 Figure 24. Top 5 and Top 10 Global Animal-base Gelatin Haemostatic Sponge Players: Market Share by Revenue in Animal-base Gelatin Haemostatic Sponge in 2025
 Figure 25. Animal-base Gelatin Haemostatic Sponge Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Global Animal-base Gelatin Haemostatic Sponge Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 27. North America Animal-base Gelatin Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 28. North America Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 29. United States Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Canada Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Europe Animal-base Gelatin Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 32. Europe Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 33. Germany Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. France Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. U.K. Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Italy Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Russia Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Asia Pacific Animal-base Gelatin Haemostatic Sponge Sales Market Share by Region (2021–2032)
 Figure 39. Asia Pacific Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Region (2021–2032)
 Figure 40. China Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Japan Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. South Korea Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. India Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Australia Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. China Taiwan Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Southeast Asia Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Animal-base Gelatin Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Colombia Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. UAE Animal-base Gelatin Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of Animal-base Gelatin Haemostatic Sponge by Type (2021–2032)
 Figure 59. Global Revenue Market Share of Animal-base Gelatin Haemostatic Sponge by Type (2021–2032)
 Figure 60. Global Animal-base Gelatin Haemostatic Sponge Price (US$/Unit) by Type (2021–2032)
 Figure 61. Global Sales Market Share of Animal-base Gelatin Haemostatic Sponge by Application (2021–2032)
 Figure 62. Global Revenue Market Share of Animal-base Gelatin Haemostatic Sponge by Application (2021–2032)
 Figure 63. Global Animal-base Gelatin Haemostatic Sponge Price (US$/Unit) by Application (2021–2032)
 Figure 64. Animal-base Gelatin Haemostatic Sponge Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS